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Objectives: To prospectively evaluate the incidence and consequences of residual arteriovenous (AV)-fistulae after 
"closed" in situ bypass grafting. 
Methods: In 34 patients, 35 "closed" in situ bypasses were performed. Postoperative assessment of residual AV-fistulae 
and bypass patency was performed with duplex scanning. 
Results: Postoperative mortality was 3%. During 35 "closed" in situ bypass procedures 216 side branches were coil 
embolised. Postoperatively 39 AV-fistulae were detected (15% of the total number of 216 + 39 =255 side branches). Of 
these, 13 (5%) closed spontaneously. Fifteen (6%) remained unchanged and 11 (4%) were treated. In three patients four 
asymptomatic residual AV-fistulae were treated. In four patients seven symptomatic A V-fistulae were treated for: decreased 
distal bypass flow in one; persistent leg oedema in one; pain and redness of the skin in two. One-year primary patency 
was 80% ( S E 8.4%). Residual AV-fistulae were detected in none of six bypass occlusions during follow-up. 
Conclusion: Residual A V-fistulae detected following "closed" in situ bypass grafting only need treatment if they are 
symptomatic, which is uncommon. 
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Introduction 
In situ vein infrainguinal bypass is one of the preferred 
techniques for treatment of lower extremity ischaemia. 
The standard "open" technique, using ligation of the 
side branches via a long skin incision, is associated 
with wound complication rates up to 44%. 1'2 To reduce 
the number of postoperative wound complications, 
"closed" in situ bypass techniques, using peroperative 
endovascular coil embolisation of vein side branches, 
have been developed. 3'4 A disadvantage of these 
"closed" techniques is the high incidence of post- 
operative residual arteriovenous (AV)-fistulae. Cikrit 
et aI., 5 who used the electronically steerable nitinol 
catheter system as first used by Rosenthal et al., 3 re- 
ported that 39% of the patients were treated for re- 
sidual AV-fistulae after "dosed" in situ bypass grafting. 
We have reported that 42% of the patients were treated 
for residual AV-fistulae after "closed" in situ bypass 
grafting, using a co-axial catheter system in a ran- 
domised study comparing the "closed" technique to 
the "open" technique. 6 Rosenthal et aI., however, only 
* Please address all correspondence to: C. H. A. Wittens, Department 
of Surgery, St Franciscus Gasthuis, Kleiweg 500, 3045 PM Rotterdam, 
The Netherlands. 
treated 6% residual AV-fistulae after refinement of the 
electronically steerable nitinol catheter and increased 
operator experience with the "closed" technique. 7 
The purpose of this study was to evaluate the in- 
cidence and consequences of residual AV-fistulae after 
"closed" in situ bypass grafting using a co-axial cath- 
eter system for peroperative ndovascular coil em- 
bolisation of the vein side branches. 
Patients and Methods 
From June 1992 to March 1996, 35 "closed" in situ 
bypasses were performed in 34 patients (23 male, 11 
female) in the St Franciscus Gasthuis, Rotterdam. The 
mean age was 73 years (range 55-90) and indications 
for operation were non-healing ulcers or necrosis in 
16, restpain in seven and life-style limiting/disabling 
claudication i  11. Fourteen (41%) patients had a smok- 
ing history, 17 (50%) had ischaemic heart disease, 17 
(50%) had hypertension and six (18%) were diabetic. 
Seventeen femorodistal popliteal and 18 femorocrural 
bypasses were performed. 
The "closed" in situ bypass technique used was 
described by Wittens et al. 4 The main characteristics 
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Fig. 1. Results of follow-up of 35 bypasses. AVF = AV-fistulae; B= bypass. 
of this method are: the valvul0tomy procedure is 
performed "blindly" with a disposable variable valve 
cutter; the side branches of the vein are coil embolised 
via a co-axial embolisation catheter under fluoroscopic 
control. The disposable materials needed for this pro- 
cedure (valvecutter, embolisation catheter and 10 em- 
bolisation coils) are commercially available as a set 
(Cook Europe, Denmark). 
During the follow-up period duplex scanning was 
performed within 4 weeks after the operation, every 
3 months postoperatively in the first year and every 
6 months thereafter for assessment of graft patency 
and occurrence of AV-fistulae. The Kaplan Meier life- 
table method was used to estimate the probability of 
bypass patency. Primary patency rates were calculated 
without taking into account operations and/or in- 
terventions for treatment of residual AV-fistula. 
Results 
The postoperative mortality was 3%: one patient died 
in the first week following the operation because of 
cardiac failure. In 35 "closed" in situ bypasses a total 
number of 216 side branches (mean 6.2 per patient) 
were coil embolised uring the bypass procedure. The 
mean follow-up was 21 months (range 1-48). Bypass 
patency rates are shown in Fig. 1. The 1 year primary 
patency rate was 80% (s.E. 8.4%). During the follow- 
up period six bypasses occluded. In none of these 
patients had residual AV-fistulae been detected uring 
follow-up before occlusion. Postoperatively, in 21 of 
the 35 bypasses a total number of 39 AV-fistulae were 
detected. The total number of vein side branches de- 
tected intraoperatively and postoperatively was there- 
fore 255. In other words 15% (39) of the total number 
of side branches were only detected postoperatively 
13 AVF (12B) spontaneous closure 
15 AVF (9B) unchanged 
7 AVF (4B) treated 
(symptomatic) 
4 AVF (3B) treated 
(asymptomatic) 
as AV-fistulae. Figure 2 shows the outcome of these 
AV-fistulae. A total number of 13 (5%) of these AV- 
fistulae in 12 patients closed spontaneously after a 
mean follow-up period of 8 months (range 1-30). 
Fifteen AV-fistulae (6%) in nine patients remained 
unchanged for a mean follow-up period of 13 months 
(range 1-22) and 11 (4%) were treated: in three patients 
four asymptomatic residual AV-fistulae were treated; 
in two patients 1 week and in one patient 1 month 
postoperatively. Seven symptomatic AV-fistulae in four 
patients were treated. The reasons for treatment were 
as follows: two AV-fistulae causing continuous ret- 
rograde diastolic flow distally in one patient were 
treated 8 months postoperatively with cessation of 
diastolic flow. Two AV-fistulae were associated with 
persistent leg oedema in one patient and treated suc- 
cessfully 3 months postoperatively. Pain and redness 
of the skin was caused by three AV-fistulae in two 
patients and were treated successfully 2 days post- 
operatively. 
All but three residual AV-fistulae were detected at 
the first duplex examination. In one patient an AV- 
fistula was detected at the first examination and three 
additional AV-fistulae were detected 2 months later. 
These four AV-fistulae remained asymptomatic for the 
follow-up period of 23 months. 
Discussion 
Management of residual AV-fistulae after in situ bypass 
grafting is a controversial issue. Symptoms attributed 
to residual AV-fistulae include bypass occlusion, 
diminished bypass function, leg oedema and skin 
symptoms. 8 In this study no bypass occlusion was 
associated with detected residual AV-fistulae. How- 
ever, other investigators have reported that residual 
AV-fistulae can cause bypass occlusion, especially the 
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Fig. 2. Primary patency rates. Numbers between brackets indicate bypasses atrisk. 
segment distal of the AV-fistula. 9-11 In this study duplex 
scanning showed continuous retrograde diastolic 
blood flow in a bypass segment distal of two large 
residual AV-fistulae in one patient. Treatment of these 
AV-fistulae restored normal blood flow. Leopold et al. 
reported similar experiences treating impaired bypass 
function, without occlusion, by closure of residual AV- 
fistulae. 12 In one patient in our study, persistent leg 
oedema was associated with residual AV-fistulae and 
treated successfully by AV-fistula ligation. Chang et al. 
reported successful treatment ofpersistent leg oedema 
by closure of residual AV-fistulae in four patients after 
216 in situ bypasses. 8 
Besides bypass failure and leg oedema, other symp- 
toms attributed to residual AV-fistulae include redness 
and tenderness of a focal skin area. These AV-fistulae 
with a connection to the skin tend to occlude spon- 
taneously, s Therefore a conservative attitude towards 
these AV-fistulae is a good option. We started by 
obliterating all residual AV-fistulae in patients uf- 
fering skin redness and pain. However, after two 
patients we changed our policy to a more conservative 
attitude and treated skin symptoms by local ap- 
plication of a compressive bandage. Symptoms ub- 
sided in all patients within 1 week. Accordingly, we 
did not close any other residual AV-fistulae for this 
reason. Leather et al. reported only 1 patient with skin 
necrosis after 1038 in situ bypasses. 13 In the early 
phase after the introduction of "closed" in situ bypass 
grafting, we treated three patients for AV-fistulae that 
were asymptomatic. This policy was also changed to 
a more conservative approach, after which no 
asymptomatic residual AV-fistulae were treated any 
more. 
The incidence of residual AV-fistulae detected in this 
study is rather high. Rosenthal et al. reported that 6% 
(three patients) of the patients were postoperatively 
treated for residual AV-fistulae with a diameter larger 
than 2 mm. Numbers of smaller esidual AV-fistulae 
were not mentioned. Rosenthal et al.'s group had coil 
embolised 258 side branches during 53 "closed" in situ 
bypass procedures (average of 4.9 side branches per 
bypass). 6 In this study we coil embolised an average 
of 6.2 side branches per bypass operation. We think that 
the technical differences ofthe embolisation catheters are 
not a logical explanation for the difference in residual 
AV-fistula incidence. Theoretically the electronically 
steerable nitinol catheter as used by Rosenthal etal. (CRI, 
Catheter Research, Inc., Indianapolis, IN, U.S.A.) is ideal 
for selective catheterisation f difficult angled side 
branches. We learned that with a co-axial system (Cook 
Europe, Denmark)it s also possible to selectively cath- 
eterise difficult angled side branches. A probable ex- 
planation for the different incidence of detected residual 
AV-fistulae could be that we also detected AV-fistulae 
smaller than 2 ram. Small tributaries might have been 
missed during intraoperative fluoroscopy due to com- 
petent valves at the orifice. These sufficient valves can 
dilate under arterial pressure and become incompetent 
resulting in residual AV-fistulae. 
After gaining some xperience with the "closed" tech- 
nique, we developed a policy not to aim at closure of all 
vein side branches in all cases: side branches that were 
very small or were very difficult o catheterise and coil 
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embolise within 10 minutes per-operatively were left 
open, because we felt that these side branches were 
usually of no consequence. An advantage of this policy 
is that the peroperative embolisation procedure took 
only 20-40 min, since no time was lost with prolonged 
attempts for catheterisation f small side branches and/ 
or additional skin incisions for surgical ligation. In this 
series one-third of the AV-fistulae occluded spon- 
taneously and 15 of the persistent fistulae remained 
asymptomatic during follow-up. Only four patients 
with residual AV-fistulae were treated for symptoms 
and the two with local skin redness and pain could 
probably have been treated conservatively. Therefore it
is reasonable to assume that only in two (6%) of the 35 
bypasses did residual AV-fistulae need treatment. No 
AV-fistula related occlusions occurred and bypass pat- 
ency rates were comparable to other series of "closed" 
and "open" in situ bypasses. 6'~4'15 Because asymptomatic 
AV-fistulae do not threaten bypass patency, specific fol- 
low-up for AV-fistula detection seems unnecessary. 
In conclusion, we have shown that the incidence of 
detected residual AV-fistulae after "closed" in situ by- 
pass grafting was 15% of the total number of vein side 
branches. When residual AV-fistulae are detected after 
"closed" in situ bypass grafting, they only need treat- 
ment in a minority of patients that are 
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